Abstract

Histoid leprosy is a rare variant of leprosy with distinctive immunological, clinical, microbiological, and histological characteristics first described by Wade in the year 1963. This is usually reported following dapsone monotherapy, irregular or improper therapy, and rarely de novo. Early diagnosis and treatment of histoid is important as it might serve as a reservoir and source of community spread of leprosy. In this article, we highlight the important aspects of clinical manifestations, immunological, histological, bacteriological, and management aspects of histoid leprosy.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.